The European Commission has developed a question -and- answer document to provide guidance to pharmaceutical companies regarding some regulatory measures that can be applied with the aim of coping with the consequences of COVID-19.

The guide has been enacted by The European Commission, the European Medicines Agency (EMA) and the European Medicines Regulatory Network.

click on the image to download